Trials to evaluate small vessel and long lesion versions of platinum chromium PROMUS(R) Element(TM) Stent System NATICK, Mass., March 16 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE:BSX ) today announced the completion of patient enrollment …
Devices, Interventional Cardiology
Boston Scientific, platinum chromium, PROMUS Element, drug eluting stent

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Boston Scientific Completes Enrollment in PLATINUM Trials for Diminutive Vessels and Long Lesions”
Leave a Comment